查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球液态栓塞剂市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按适应症、按最终用户、按地区
市场调查报告书
商品编码
1420309

全球液态栓塞剂市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按适应症、按最终用户、按地区

Liquid Embolic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 280 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球液态栓塞剂市场规模为2.7亿美元，预计2031年将达到约5.805亿美元，复合年增长率（CAGR）为8.9%，预计将带来显着成长弹道。

目前液体栓塞瓶在全球市场占据82.7%的主要份额。儘管液体栓塞产品已成功用于治疗动静脉畸形，但其在动脉瘤治疗中的应用仅限于有限数量的患者，主要是由于担心阻止液体迁移到载瘤血管中。

过去五年，全球液体栓塞剂市场以 4.2% 的复合年增长率扩张。栓塞是一种微创手术，用于阻塞一条或多条血管或异常血管通道。各种栓塞剂透过导管引入血管以阻止血液流向特定区域。液体栓塞剂如氰基丙烯酸正丁酯（NBCA）和乙基乙烯醇共聚物在栓塞治疗中发挥重要作用。

预计未来十年对液体栓塞剂的需求将大幅成长，复合年增长率约为 8.9%。预计从 2024 年到 2031 年，这一成长将带来 3.334 亿美元的额外机会。与液体预填充注射剂相比，液体栓塞瓶预计在整个预测期内将保持较高的需求。

由于全球肿瘤发生率不断增加，肿瘤栓塞为液体栓塞剂製造商带来了重大机会。这种微创手术要么切断肿瘤的血液供应，要么直接向肿瘤施用抗肿瘤药物。

该报告研究了全球液体栓塞剂市场，并提供了市场概述，包括按产品、适应症、最终用户、区域划分的趋势以及进入市场的公司的竞争趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第三章 2018-2023年生产与贸易统计

第四章 2018-2023年价格分析

第五章 2018-2031 年全球液态栓塞剂市场展望

  • 全球液体栓塞剂市场展望，按产品，价值（百万美元），数量（单位），2018-2031
  • 2018-2031 年全球液体栓塞剂市场前景（按适应症、价值（百万美元）、数量（单位））
  • 全球液体栓塞剂市场展望，按最终用户、价值（百万美元）、数量（单位），2018-2031
  • 全球液体栓塞剂市场展望，按地区、价值（百万美元）、数量（单位），2018-2031

第六章 北美液体栓塞剂市场展望，2018-2031

第 7 章 2018-2031 年欧洲液态栓塞剂市场展望

第 8 章 2018-2031 年亚太地区液体栓塞剂市场展望

第 9 章 2018-2031 年拉丁美洲液态栓塞剂市场展望

第 10 章 2018-2031 年中东和非洲液态栓塞剂市场展望

第十一章竞争格局

  • 最终用户热图和指示
  • 2023 年公司市场份额分析
  • 比赛仪表板
  • 公司简介
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Johnson & Johnson
    • Wright Medical Group N.V.
    • Microvention Inc.
    • Terumo Corporation
    • Guerbet
    • Emboflu
    • Boston Medical Corporation

第十二章附录

简介目录

The global liquid embolic market, valued at US$ 270 million in 2024, is set to experience a significant growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 8.9% to reach a market valuation of approximately US$ 580.5 million by 2031, according to a recent market analysis by Fairfield Market.

Liquid Embolic Vials Dominate Market Share

Liquid embolic vials currently hold a substantial share of 82.7% in the global market. While liquid embolic products have been successfully used in the treatment of arteriovenous malformations, their application in aneurysm treatment remains limited to a select group of patients, primarily due to concerns about preventing the migration of the liquid to the parent vessel.

Demand Analysis and Growth Prospects

The global market for liquid embolics has expanded at a CAGR of 4.2% over the past five years. Embolization is a minimally invasive procedure used to block one or more blood vessels or abnormal vascular channels. Various embolic agents are introduced through catheters into blood vessels to inhibit blood flow to specific areas, with liquid embolic agents such as n-Butyl Cyanoacrylate (NBCA) and ethyl vinyl alcohol copolymers playing a vital role in therapeutic embolization.

The demand for liquid embolic products is expected to surge at a substantial rate over the next decade, with a projected CAGR of around 8.9%. This growth is anticipated to bring about an incremental opportunity of US$ 333.4 million from 2024 to 2031. Liquid embolic vials are expected to remain in high demand throughout the forecast period compared to liquid prefilled injectables.

Key Opportunities for Liquid Embolic Product Manufacturers

Tumor embolization presents a significant opportunity for liquid embolic product manufacturers, given the increasing incidence of tumors worldwide. This minimally invasive procedure involves shutting down the blood supply to tumors or delivering tumor-killing therapy directly to them.

Companies developing liquid embolic agents could expand their market share by pursuing regulatory approvals for indications beyond neuro interventional, tapping into the rising prevalence of cancer. Additionally, the growing demand for neurovascular embolization devices, driven by an increasing prevalence of cerebral aneurysms, offers further market growth prospects.

Advancements in research and development also provide opportunities for both emerging and established liquid embolic product suppliers to establish a strong presence in the market.

Factors Restraining Demand for Liquid Embolic Systems

While the demand for liquid embolic products is on the rise, certain challenges must be addressed. These include issues such as balloon deflation, catheter entrapment, and difficulties in deploying the device to the targeted lesion. Moreover, the high risk associated with liquid embolic procedures, including the potential of targeting the wrong blood vessels during surgical procedures, is a concern.

Additionally, limited liquid embolic agent manufacturers face intense competition from alternative transcatheter embolization devices, which could potentially restrain the growth of the liquid embolic systems market.

Country-wise Insights

The U.S.: Largest Regional Liquid Embolic Market

The United States dominates the North America liquid embolic market, with a substantial market share. This dominance is driven by factors such as unhealthy lifestyle habits, including junk food consumption, smoking, and alcohol use, as well as a sedentary lifestyle. These habits have led to a higher prevalence of chronic diseases like high blood pressure, migraines, and bAVM, increasing the demand for liquid embolic products and agents in the U.S. Moreover, lifestyle changes have been associated with a significant percentage of cancer cases in the country, further contributing to the demand for such products.

Germany: A Lucrative Market in Europe

Germany is expected to be a prominent player in the European market for liquid embolics. This is primarily due to the substantial number of clinical trials and research conducted in the country, particularly in the field of cancer research. Germany boasts a significant number of research ethics committees, with active government involvement in healthcare and cancer-related research and innovation. This environment presents lucrative opportunities for suppliers of liquid embolic products to grow in the market.

South Korea: An Emerging Market

South Korea is an emerging market in the East Asia liquid embolic market. The country is witnessing substantial growth in this sector, mainly due to the increasing prevalence of cardiovascular diseases. For instance, coronary heart disease-related deaths in South Korea have been a significant concern. This growth in cardiovascular issues has led to a rising demand for liquid embolic products and is expected to continue to expand in the coming years.

Competitive Analysis

Leading liquid embolic product providers are adopting growth strategies such as new product launches, approvals, agreements, collaborations, and partnerships. These strategies are helping key stakeholders expand their geographic footprint and strengthen their existing product portfolios.

Key Companies Profiled:

  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Johnson & Johnson
  • Microvention Inc.
  • Terumo Corporation
  • Guerbet
  • Emboflu

Key Segments Covered in Liquid Embolic Industry Research

Liquid Embolic Market by Product

  • Liquid Embolic Vials
  • Liquid Embolic Prefilled Injectables

Liquid Embolic Market by Indication

  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Radiology
  • Cardiology

Liquid Embolic Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Speciality Centres

Liquid Embolic Market by Region

  • North America Liquid Embolic Market
  • Latin America Liquid Embolic Market
  • Europe Liquid Embolic Market
  • East Asia Liquid Embolic Market
  • South Asia Liquid Embolic Market
  • Oceania Liquid Embolic Market
  • Middle East & Africa (MEA) Liquid Embolic Market

Table of Contents

1. Executive Summary

  • 1.1. Global Liquid Embolic Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Liquid Embolic Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Liquid Embolic Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Liquid Embolic Market Outlook, 2018 - 2031

  • 5.1. Global Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Liquid Embolic Vials
      • 5.1.1.2. Liquid Embolic Prefilled Injectables
  • 5.2. Global Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 5.2.1.2. Tumor Embolization
      • 5.2.1.3. Radiology
      • 5.2.1.4. Cardiology
  • 5.3. Global Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Ambulatory Surgical Centers
      • 5.3.1.3. Independent Speciality Centres
  • 5.4. Global Liquid Embolic Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Liquid Embolic Market Outlook, 2018 - 2031

  • 6.1. North America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Liquid Embolic Vials
      • 6.1.1.2. Liquid Embolic Prefilled Injectables
  • 6.2. North America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 6.2.1.2. Tumor Embolization
      • 6.2.1.3. Radiology
      • 6.2.1.4. Cardiology
  • 6.3. North America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Ambulatory Surgical Centers
      • 6.3.1.3. Independent Speciality Centres
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook, 2018 - 2031

  • 7.1. Europe Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Liquid Embolic Vials
      • 7.1.1.2. Liquid Embolic Prefilled Injectables
  • 7.2. Europe Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 7.2.1.2. Tumor Embolization
      • 7.2.1.3. Radiology
      • 7.2.1.4. Cardiology
  • 7.3. Europe Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Ambulatory Surgical Centers
      • 7.3.1.3. Independent Speciality Centres
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Liquid Embolic Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Liquid Embolic Vials
      • 8.1.1.2. Liquid Embolic Prefilled Injectables
  • 8.2. Asia Pacific Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 8.2.1.2. Tumor Embolization
      • 8.2.1.3. Radiology
      • 8.2.1.4. Cardiology
  • 8.3. Asia Pacific Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Ambulatory Surgical Centers
      • 8.3.1.3. Independent Speciality Centres
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Liquid Embolic Market Outlook, 2018 - 2031

  • 9.1. Latin America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Liquid Embolic Vials
      • 9.1.1.2. Liquid Embolic Prefilled Injectables
  • 9.2. Latin America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 9.2.1.2. Tumor Embolization
      • 9.2.1.3. Radiology
      • 9.2.1.4. Cardiology
  • 9.3. Latin America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Ambulatory Surgical Centers
      • 9.3.1.3. Independent Speciality Centres
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Liquid Embolic Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Liquid Embolic Vials
      • 10.1.1.2. Liquid Embolic Prefilled Injectables
  • 10.2. Middle East & Africa Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 10.2.1.2. Tumor Embolization
      • 10.2.1.3. Radiology
      • 10.2.1.4. Cardiology
  • 10.3. Middle East & Africa Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
      • 10.3.1.3. Independent Speciality Centres
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Indication Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Medtronic
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Meril Life Sciences Pvt. Ltd.
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Johnson & Johnson
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Wright Medical Group N.V.
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Microvention Inc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Terumo Corporation
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Guerbet
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Emboflu
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Boston Medical Corporation
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations